<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR1301.html">Part 1301
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1301.51  Modification in registration.
                            </h3>
                            <p class="depth1"><em>(a)</em> Any registrant may apply to modify his/her registration to  authorize the handling of additional controlled substances or to change  his/her name or address by submitting a written request to the  Registration Unit, Drug Enforcement Administration. See the Table of DEA  Mailing Addresses in Sec. 1321.01 of this chapter for the current  mailing address. Additionally, such a request may be submitted on-line  at www.DEAdiversion.usdoj.gov.</p><p class="depth2"><em>(1)</em> The request shall contain:</p><p class="depth3"><em>(i)</em> The registrant's name, address, and registration number as  printed on the certificate of registration;</p><p class="depth3"><em>(ii)</em> The substances and/or schedules to be added to the registration  or the new name or address; and</p><p class="depth3"><em>(iii)</em> A signature in accordance with Sec. 1301.13(j).</p><p class="depth2"><em>(2)</em> If the registrant is seeking to handle additional controlled  substances listed in Schedule I for the purpose of research or  instructional activities, the registrant shall attach three copies of a  research protocol describing each research project involving the  additional substances, or two copies of a statement describing the  nature, extent, and duration of such instructional activities, as  appropriate.</p><p class="depth1"><em>(b)</em> Any manufacturer, distributor, reverse distributor, narcotic  treatment program, hospital/clinic with an on-site pharmacy, or retail  pharmacy registered pursuant to this part, may apply to modify its  registration to become authorized as a collector by submitting a written  request to the Registration Unit, Drug Enforcement Administration. See  the Table of DEA Mailing Addresses in Sec. 1321.01 of this chapter for  the current mailing address. Additionally, such request may be submitted  on-line at www.DEAdiversion.usdoj.gov.</p><p class="depth2"><em>(1)</em> The request shall contain:</p><p class="depth3"><em>(i)</em> The registrant's name, address, and registration number as  printed on the certificate of registration;</p><p class="depth3"><em>(ii)</em> The method(s) of collection the registrant intends to conduct  (collection receptacle and/or mail-back program); and</p><p class="depth3"><em>(iii)</em> A signature in accordance with Sec. 1301.13(j).</p><p class="depth2"><em>(2)</em> If a hospital/clinic with an on-site pharmacy or retail pharmacy  is applying for a modification in registration to authorize such  registrant to be a collector to maintain a collection receptacle at a  long-term care facility in accordance with Sec. 1317.80 of this  chapter, the request shall also include the name and physical location  of each long-term care facility at which the   hospital/clinic with an on-site pharmacy, or the retail pharmacy,  intends to operate a collection receptacle.</p><p class="depth1"><em>(c)</em> No fee shall be required for modification. The request for  modification shall be handled in the same manner as an application for  registration. If the modification of registration is approved, the  Administrator shall issue a new certificate of registration (DEA Form  223) to the registrant, who shall maintain it with the old certificate  of registration until expiration.  [79 FR 53561, Sept. 9, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
